Skip to content
Open access

Integrated In-Silico Approach to Elucidate the Anticholestatic Potential of Garcinia indica Choisy Against Clavulanic AcidInduced cholestasis

Oct 2026 · International Journal of Drug Delivery Technology · 0 citations · 57 references

Abstract

indica represents a structurally rational, multi-target natural product candidate for the pharmacological management of drug-induced cholestasis Abstract Background and Purpose: Drug-induced cholestasis (DIC), a clinically significant subtype of drug-induced liver injury (DILI), is characterized by impaired bile acid homeostasis, oxidative stress, and progressive hepatocellular damage. Clavulanic acid (CLAV), the primary hepatotoxic component of amoxicillin-clavulanate (AC), disrupts farnesoid X receptor (FXR) and NRF2 signalling while regulatory pathway, leading to impaired BSEP-mediated bile acid transport, activation of inflammatory signalling, and altered cholesterol metabolism through HMGCR dysregulation. Current therapeutic options remain limited in efficacy, creating a need for safer and more effective multi-target approaches. Garcinia indica Choisy, a medicinal plant rich in flavonoids and polyisoprenylated benzophenones, was investigated for its potential anticholestatic activity. Experimental Approach: 69 phytoconstituents of G. indica were screened using ADMET profiling. Network pharmacology analysis was performed to identify overlapping targets associated with clavulanic acid-induced cholestasis. Four key proteins involved in disease progression FXR, BSEP, TNF-α, and HMGCR-were selected for molecular docking studies, followed by 100 ns molecular dynamics simulation to assess complex stability. Key Results: 24 compounds satisfied the drug-likeness and safety criteria. The identified 101 overlapping targets enriched the pathways related to bile secretion, ABC transporters, cholesterol metabolism, NF-kB signalling, and PI3K-Akt signalling. Docking analysis demonstrated strong binding affinities of apigenin toward FXR (-9.1 kcal/mol), isoxanthochymol toward TNF-α (-10.0 kcal/mol), quercetin toward BSEP (-8.3 kcal/mol), and morelloflavone toward HMGCR (-8.3 kcal/mol). Molecular dynamics simulation further supported the stability of the lead ligand-protein complexes throughout the simulation period. Conclusion and Implications: The study suggests that G. indica phytoconstituents, like apigenin and morelloflavone, may have promising multi-target potential against cholestasis caused by clavulanic acid and further, need to be validated through experimental investigations.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.